Loading
A phase 3 trial of Socazolimab run by Lee's Pharmaceutical Limited in cervical cancer, now recruiting.
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer is a phase 3 interventional study registered as NCT06459687 by Lee's Pharmaceutical Limited, with 440 participants planned, started 2024-11-28. Conditions listed: Cervical Cancer. No results are recorded here; the registry entry is the source.
Shares Recurrent or metastatic cervical cancer, Cervical cancer, Immune checkpoint inhibitors.
Shares Recurrent or metastatic cervical cancer, Cervical cancer, Immune checkpoint inhibitors.
Shares Recurrent or metastatic cervical cancer, Cervical cancer, Immune checkpoint inhibitors.
Shares Recurrent or metastatic cervical cancer, Cervical cancer.
Shares Recurrent or metastatic cervical cancer, Cervical cancer, Immune checkpoint inhibitors.
Shares Recurrent or metastatic cervical cancer, Cervical cancer.
Shares Recurrent or metastatic cervical cancer, Cervical cancer, Immune checkpoint inhibitors.
Shares Recurrent or metastatic cervical cancer, Cervical cancer.